Intermuscular fat density as a novel prognostic factor in breast cancer patients treated with adjuvant chemotherapy
Authors:
- 20 July 2021
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 189 (3) , 759-768
Abstract
Background Body composition, including sarcopenia and fat parameters, has received much attention as a prognostic factor in breast cancer. Methods A total of 479 breast cancer patients who underwent surgery and received adjuvant chemotherapy were enrolled in this study. Body composition, including the index and density of skeletal muscle, visceral fat, subcutaneous fat, and intermuscular fat calculated by CT scan, was used as a prognostic factor. The endpoints were breast cancer-specific survival (BCSS) and overall survival (OS). Results The number of patients with stages I, II, and III was 146 (30.5%), 237 (49.5%), and 96 (20%), respectively. Sarcopenia and muscle density were not significant prognostic factors for BCSS and OS. A high visceral fat index (VFI) was an independent prognostic factor for BCSS (HR, 2.55; 95% CI 1.10–5.95, p = 0.03) and OS (HR 2.55, 95% CI 1.26–5.16, p = 0.01). In addition, high intermuscular fat density (IMFD) was also a significant prognostic factor for BCSS (HR, 2.95; 95% CI 1.34–6.46, p = 0.007) and OS (HR 2.28, 95% CI 1.22–4.26, p = 0.01) in multivariate analysis. Conclusion VFI and IMFD were significant prognostic factors for BCSS and OS in breast cancer patients treated with adjuvant chemotherapy.Keywords
Funding Information
- Korea Health Industry Development Institute (HI18C1216)
- National Research Foundation of Korea (2020R1C1C1013598)
- Catholic University of Korea (the program year of 2020)
This publication has 37 references indexed in Scilit:
- High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingEuropean Journal of Cancer, 2015
- Fat Quality and Incident Cardiovascular Disease, All-Cause Mortality, and Cancer MortalityThe Journal of Clinical Endocrinology & Metabolism, 2015
- Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studiesAnnals of Oncology, 2014
- Intermuscular Fat: A Review of the Consequences and CausesInternational Journal of Endocrinology, 2014
- Metabolically healthy obesity: epidemiology, mechanisms, and clinical implicationsThe Lancet Diabetes & Endocrinology, 2013
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass IndexJournal of Clinical Oncology, 2013
- Physical and Clinical Assessment of Nutrition Status2013
- The Relationship Between Body Composition and Response to Neoadjuvant Chemotherapy in Women with Operable Breast CancerThe Oncologist, 2012
- Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell LineJournal of Biological Chemistry, 2003
- An application of changepoint methods in studying the effect of age on survival in breast cancerComputational Statistics & Data Analysis, 1999